FDA Regulatory Insights & Compliance Guides

This four-part series is designed to transform the complex process of FDA market access into a clear, strategic framework. Over the next four weeks, we will cover: Part 1 (Current): All Major US Market Entry Pathways for Drugs (The Landscape) Part 2: Pathway Selection Framework (The Decision Matrix) Part 3: ROI Feasibility Calculator (The Financial Tool) Part 4: Detailed Pathway Analysis with ROI (The Case Studies) The US Drug Market: A Labyrinth or a Highway? Entering t

For decades, vaccine developers have relied on immunobridging to speed up approval of updated vaccines. This approach allowed regulators to approve new or modified vaccines by comparing immune responses to those of already-approved vaccines, avoiding lengthy and costly efficacy trials. Now, the U.S. Food and Drug Administration (FDA) is moving away from this shortcut. Instead, it proposes a more rigorous system based on establishing a Correlate of Protection (CoP). This chang

Entering the U.S. cosmetics market offers a huge opportunity for foreign brands, but it comes with strict regulatory requirements. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) sets new standards that every cosmetic product must meet before it can be sold in the United States. For brands manufacturing products outside the U.S., compliance is not just about marketing or sales—it’s about ensuring your product passes customs inspections and avoids costly delays

Entering the pharmaceutical market requires a clear strategy and thorough understanding of regulatory landscapes. Companies must navigate complex rules, compliance requirements, and competitive dynamics to succeed. I will share practical insights and actionable recommendations to help you plan and execute a successful market entry. Pharma Market Entry Tips for Global Success To start, focus on understanding the target market . Each region has unique regulatory frameworks, hea

Global manufacturers face significant challenges when exporting pharmaceutical and nutraceutical products to the United States. The U.S. Food and Drug Administration (FDA) enforces strict import regulations to ensure product safety and regulatory compliance. Yet, many import delays and refusals arise not from product quality but from avoidable documentation and procedural errors. Understanding these common pitfalls and implementing preventive measures can save time, reduce co